Big Changes Ahead For IRBs Regarding DCTs
Source: Clinical Leader
After reviewing the new FDA Guidance on DCTs, Dr. Daniel Fox, founder and CEO of the Clinical Research Payment Network (CRPN), predicts that IRBs are going to have their hands full in the future when it comes to the acceptance and adoption of DCTs.
View the full presentation here.
This website uses cookies to ensure you get the best experience on our website. Learn more